nei THIS MONTH IN
PSYCHOPHARMACOLOGY
Psychotropic Medications and COVID-19
July 20, 2020   

As COVID-19 spreads worldwide, there are many questions arising in terms of how best to care for individuals who are infected. In this comprehensive article, Bilbul and colleagues explore some of the various concerns in terms of the potential impact of psychotropic medications on the various organ systems that are often affected by COVID-19 as well as how psychotropic medications may interact with agents used to treat COVID-19 patients (such as remdesvir and hydroxychloroquine) (Tables 1 and 2). For instance, COVID-19 often affects cardiac function and some of the medications used to treat COVID-19 can prolong the QTc interval; therefore, caution is warranted when utilizing psychotropic medications that can also impact the QTc interval. These data will be vey useful for guiding practice when addressing the psychiatric needs of patients with COVID-19.


Reference:

Bilbul M et al. Psychosomatics 2020; Epub ahead of print. Abstract


For more information:

This Month In Psychopharmacology